Role of Cannabinoid CB1, Receptor in Object Recognition Memory Impairment in Chronically Rapid Eye Movement Sleep-deprived Rats
Chinese Medical Sciences Journal · 2023
DOI: 10.24920/004087 ↗At a glance
Journal article in Chinese Medical Sciences Journal, 2023. Written by Kaveh Shahveisi and 3 co-authors. Institution: Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran. Major MEDLINE topics: Memory, Cannabinoids. Cited 8 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Kermanshah University of Medical Sciences.
Abstract (original language)
Objective
We aimed to investigate whether antagonism of the cannabinoid CB1 receptor (CB1R) could affect novel object recognition (NOR) memory in chronically rapid eye movement sleep-deprived (RSD) rats.
Methods
The animals were examined for recognition memory following a 7-day chronic partial RSD paradigm using the multiple platform technique. The CB1R antagonist rimonabant (1 or 3 mg/kg, i.p.) was administered either at one hour prior to the sample phase for acquisition, or immediately after the sample phase for consolidation, or at one hour before the test phase for retrieval of NOR memory. For the reconsolidation task, rimonabant was administered immediately after the second sample phase.
Results
The RSD episode impaired acquisition, consolidation, and retrieval, but it did not affect the reconsolidation of NOR memory. Rimonabant administration did not affect acquisition, consolidation, and reconsolidation; however, it attenuated impairment of the retrieval of NOR memory induced by chronic RSD.
Conclusions
These findings, along with our previous report, would seem to suggest that RSD may affect different phases of recognition memory based on its duration. Importantly, it seems that the CB1R may, at least in part, be involved in the adverse effects of chronic RSD on the retrieval, but not in the acquisition, consolidation, and reconsolidation, of NOR memory.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.
- Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah 6714869914, Iran.
- Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari 48175866, Iran.
- PDepartment of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari 48175866, Iran.
- Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851451, Iran.
Funding
- Kermanshah University of Medical Sciences
Cite
APA
Shahveisi, K., Marziyeh Hadi, S., Ghazvini, H., & Khodamoradi, M. (2023). Role of Cannabinoid CB1, Receptor in Object Recognition Memory Impairment in Chronically Rapid Eye Movement Sleep-deprived Rats. Chinese Medical Sciences Journal. https://doi.org/10.24920/004087
Vancouver
Shahveisi K, Marziyeh Hadi S, Ghazvini H, Khodamoradi M. Role of Cannabinoid CB1, Receptor in Object Recognition Memory Impairment in Chronically Rapid Eye Movement Sleep-deprived Rats. Chinese Medical Sciences Journal. 2023. doi:10.24920/004087
BibTeX
@article{Shahveisi2023,
author = {Shahveisi, Kaveh and Marziyeh Hadi, Seyedeh and Ghazvini, Hamed and Khodamoradi, Mehdi},
title = {Role of Cannabinoid CB1, Receptor in Object Recognition Memory Impairment in Chronically Rapid Eye Movement Sleep-deprived Rats},
journal = {Chinese Medical Sciences Journal},
year = {2023},
doi = {10.24920/004087}
}
EUVIMED